Sugammadex use in a patient with myastenia gravis

Volume: 55 Number: 2 June 1, 2016
  • Ebru Biricik
EN TR

Sugammadex use in a patient with myastenia gravis

Abstract

Myastenia gravis is an autoimmune disease involving the neuromuscular junction and patients receiving this diagnosis have a risk of developing postoperative respiratory failure. Similarly, the presence of chronic obstructive lung disease is known to be associated with postoperative respiratory failure. However, steroidal non-depolarising muscle relaxants and sugammadex to reverse their muscle-relaxing effects minimize the risk of postoperative respiratory failure. In this case report, we wanted to present a successful application of general anesthesia with rocuronium for emergency laparotomy in a patient with myasthenia gravis and chronic obstructive pulmonary disease in whom postoperative respiratory failure could be prevented by using sugammadex.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Ebru Biricik

Publication Date

June 1, 2016

Submission Date

June 1, 2016

Acceptance Date

-

Published in Issue

Year 2016 Volume: 55 Number: 2

Vancouver
1.Ebru Biricik. Myastenia gravis tanılı hastada sugammadex kullanımı. EJM. 2016 Jun. 1;55(2):82-3. doi:10.19161/etd.344187

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.